TABLE 5.
Summary of specificity estimates for PCR directed at pneumococcal genes in the published literature
Refer- ence | Target gene | Target size (bp) | PCR design | Specimen | Population | No. of samples | Specificity | 95% CI |
---|---|---|---|---|---|---|---|---|
21 | Pneumolysin | 348, 208 | Nested | Serum | Healthy elderly | 100 | 0.94 | 0.89-0.99 |
4 | Pneumolysin | 355 | Single step | Serum | Healthy children | 174 | 0.80 | 0.74-0.86 |
4 | Pneumolysin | 355 | Single step | Serum | Healthy adults | 28 | 1.00 | |
32 | Pneumolysin | 348, 208 | Nested | Blood fraction | Healthy children | 15 | 1.00 | |
32 | Pneumolysin | 348, 208 | Nested | Blood fraction | Sick children | 8 | 1.00 | |
1 | 16s rRNA | 1030, 300, 940 | PCR with HaeIII digest | Culture-negative CSFa | Not specified | 61 | 1.00 | |
12 | Pneumolysin | 348, 208 | Nested | Serum | Outpatient adults | 77 | 1.00 | |
11 | Pneumolysin | 348, 208 | Nested | Whole blood | Sick adults | 50 | 0.96 | 0.91-1.00 |
13 | Pneumolysin | 208 | Single step | 3 blood fractions | Healthy and sick children | 44 | 0.95 | 0.89-1.00 |
CSF, cerebrospinal fluid.